tiprankstipranks
Arbutus Biopharma (ABUS)
NASDAQ:ABUS
US Market
ABUS
Arbutus Biopharma
RESEARCH TOOLSreports
Want to see ABUS full AI Analyst Report?

Arbutus Biopharma (ABUS) Ratios

1,284 Followers

Arbutus Biopharma Ratios

ABUS's free cash flow for Q2 2026 was $1.00. For the 2026 fiscal year, ABUS's free cash flow was decreased by $ and operating cash flow was $-5.05. See a summary of the company’s cash flow.
Ratios
TTM
Dec 25Dec 24Dec 23Dec 22
Liquidity Ratios
Current Ratio
 81.42 15.73 8.15 5.87 4.60
Quick Ratio
 81.42 15.73 8.15 5.87 4.60
Cash Ratio
 5.70 3.00 2.33 1.17 0.94
Solvency Ratio
 10.01 -1.84 -2.00 -1.86 -1.16
Operating Cash Flow Ratio
 -7.32 -6.60 -4.15 -3.82 -1.08
Short-Term Operating Cash Flow Coverage
 0.00 -72.46 0.00 0.00 -95.04
Net Current Asset Value
$ 258.59M$ 76.41M$ 92.97M$ 93.64M$ 92.57M
Leverage Ratios
Debt-to-Assets Ratio
 <0.01 0.04 0.05 0.06 0.06
Debt-to-Equity Ratio
 <0.01 0.05 0.06 0.08 0.09
Debt-to-Capital Ratio
 <0.01 0.05 0.06 0.08 0.08
Long-Term Debt-to-Capital Ratio
 0.01 0.04 0.05 0.06 0.07
Financial Leverage Ratio
 1.06 1.24 1.35 1.36 1.43
Debt Service Coverage Ratio
 2.02K -51.31 -499.29 -154.65 -31.60
Interest Coverage Ratio
 1.94K -278.88 -557.07 -170.16 -37.92
Debt to Market Cap
 <0.01 <0.01 <0.01 0.02 0.03
Interest Debt Per Share
 <0.01 0.02 0.03 0.06 0.09
Net Debt to EBITDA
 -0.12 0.42 0.44 0.25 0.29
Profitability Margins
Gross Profit Margin
99.98%97.42%100.00%100.00%100.00%
EBIT Margin
84.27%-237.19%-1130.82%-399.04%-162.19%
EBITDA Margin
84.29%-234.62%-1108.46%-391.30%-158.54%
Operating Profit Margin
81.01%-192.08%-1236.74%-430.53%-167.75%
Pretax Profit Margin
84.23%-237.88%-1133.04%-401.57%-166.62%
Net Profit Margin
84.23%-237.88%-1133.04%-401.57%-178.01%
Continuous Operations Profit Margin
84.23%-237.88%-1133.04%-401.57%-178.01%
Net Income Per EBT
100.00%100.00%100.00%100.00%106.84%
EBT Per EBIT
103.97%123.84%91.62%93.27%99.32%
Return on Assets (ROA)
55.85%-35.41%-53.09%-50.45%-35.54%
Return on Equity (ROE)
90.98%-43.75%-71.81%-68.71%-50.75%
Return on Capital Employed (ROCE)
54.39%-30.53%-65.74%-64.06%-40.27%
Return on Invested Capital (ROIC)
54.29%-30.34%-65.47%-63.84%-40.17%
Return on Tangible Assets
55.85%-35.41%-53.09%-50.45%-35.54%
Earnings Yield
16.60%-3.64%-11.52%-17.56%-19.75%
Efficiency Ratios
Receivables Turnover
 1.01 8.06 2.56 10.21 28.86
Payables Turnover
 0.01 0.31 0.00 0.00 0.00
Inventory Turnover
 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover
 18.17K 440.09 1.42 2.98 5.73
Asset Turnover
 0.66 0.15 0.05 0.13 0.20
Working Capital Turnover Ratio
 0.67 0.14 0.06 0.16 0.29
Cash Conversion Cycle
 -31.16K -1.13K 142.49 35.73 12.65
Days of Sales Outstanding
 361.03 45.28 142.49 35.73 12.65
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 0.00
Days of Payables Outstanding
 31.52K 1.18K 0.00 0.00 0.00
Operating Cycle
 361.03 45.28 142.49 35.73 12.65
Cash Flow Ratios
Operating Cash Flow Per Share
 -0.12 -0.21 -0.35 -0.52 -0.23
Free Cash Flow Per Share
 -0.12 -0.21 -0.35 -0.52 -0.24
CapEx Per Share
 <0.01 0.00 <0.01 <0.01 <0.01
Free Cash Flow to Operating Cash Flow
 1.00 1.00 1.00 1.01 1.01
Dividend Paid and CapEx Coverage Ratio
 -24.63M 0.00 -356.32 -85.25 -69.05
Capital Expenditure Coverage Ratio
 -24.63M 0.00 -356.32 -85.25 -69.05
Operating Cash Flow Coverage Ratio
 -47.91 -9.46 -10.60 -9.85 -2.82
Operating Cash Flow to Sales Ratio
 -0.14 -2.81 -10.51 -4.74 -0.91
Free Cash Flow Yield
-2.67%-4.30%-10.71%-20.96%-10.20%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 5.91 -28.29 -8.61 -5.70 -5.06
Price-to-Sales (P/S) Ratio
 5.08 65.44 98.35 22.87 9.01
Price-to-Book (P/B) Ratio
 3.56 12.04 6.23 3.91 2.57
Price-to-Free Cash Flow (P/FCF) Ratio
 -37.46 -23.25 -9.33 -4.77 -9.81
Price-to-Operating Cash Flow Ratio
 -37.45 -23.25 -9.36 -4.83 -9.95
Price-to-Earnings Growth (PEG) Ratio
 <0.01 0.51 0.63 1.31 0.14
Price-to-Fair Value
 3.56 12.04 6.23 3.91 2.57
Enterprise Value Multiple
 5.90 -27.47 -8.43 -5.60 -5.39
Enterprise Value
 903.84M 907.77M 576.73M 397.34M 333.46M
EV to EBITDA
 5.90 -27.47 -8.43 -5.60 -5.39
EV to Sales
 4.97 64.46 93.46 21.90 8.55
EV to Free Cash Flow
 -36.70 -22.90 -8.87 -4.57 -9.30
EV to Operating Cash Flow
 -36.70 -22.90 -8.89 -4.62 -9.43
Tangible Book Value Per Share
 1.31 0.40 0.52 0.64 0.91
Shareholders’ Equity Per Share
 1.31 0.40 0.52 0.64 0.91
Tax and Other Ratios
Effective Tax Rate
 0.00 0.00 0.00 0.00 -0.07
Revenue Per Share
 0.92 0.07 0.03 0.11 0.26
Net Income Per Share
 0.78 -0.17 -0.38 -0.44 -0.46
Tax Burden
 1.00 1.00 1.00 1.00 1.07
Interest Burden
 1.00 1.00 1.00 1.01 1.03
Research & Development to Revenue
 0.10 1.79 8.76 4.06 2.16
SG&A to Revenue
 0.09 1.13 3.58 1.24 0.46
Stock-Based Compensation to Revenue
 0.03 0.49 1.46 0.51 0.18
Income Quality
 -0.16 1.18 0.93 1.18 0.51
Currency in USD